BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 29334905)

  • 41. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy.
    Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM
    Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.
    Grazioli L; Bondioni MP; Haradome H; Motosugi U; Tinti R; Frittoli B; Gambarini S; Donato F; Colagrande S
    Radiology; 2012 Feb; 262(2):520-9. PubMed ID: 22282184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.
    Fu GL; Du Y; Zee CS; Yang HF; Li Y; Duan RG; Zeng NL; Xiao DM
    J Comput Assist Tomogr; 2012; 36(1):14-9. PubMed ID: 22261765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Focal nodular hyperplasia and hepatocellular adenoma: The value of shear wave elastography for differential diagnosis.
    Brunel T; Guibal A; Boularan C; Ducerf C; Mabrut JY; Bancel B; Boussel L; Rode A
    Eur J Radiol; 2015 Nov; 84(11):2059-64. PubMed ID: 26299323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia.
    Gatti M; Calandri M; Bergamasco L; Darvizeh F; Grazioli L; Inchingolo R; Ippolito D; Rousset S; Veltri A; Fonio P; Faletti R
    Radiol Med; 2020 Apr; 125(4):348-355. PubMed ID: 31916102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focal nodular hyperplasia and hepatocellular adenoma of the liver: differentiation with multiphasic helical CT.
    Ruppert-Kohlmayr AJ; Uggowitzer MM; Kugler C; Zebedin D; Schaffler G; Ruppert GS
    AJR Am J Roentgenol; 2001 Jun; 176(6):1493-8. PubMed ID: 11373219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
    Agarwal S; Fuentes-Orrego JM; Arnason T; Misdraji J; Jhaveri KS; Harisinghani M; Hahn PF
    AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
    Gu K; Jeon TY; Yoo SY; Kim JH
    Eur Radiol; 2021 Jan; 31(1):283-291. PubMed ID: 32797310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of acoustic radiation force impulse imaging for the evaluation of focal liver lesion elasticity.
    Zhang P; Zhou P; Tian SM; Qian Y; Deng J; Zhang L
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):165-70. PubMed ID: 23558071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions.
    Van Hoe L; Baert AL; Gryspeerdt S; Vandenbosh G; Nevens F; Van Steenbergen W; Marchal G
    AJR Am J Roentgenol; 1997 May; 168(5):1185-92. PubMed ID: 9129409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
    Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
    J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK
    AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706
    [No Abstract]   [Full Text] [Related]  

  • 55. Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.
    Zheng SG; Xu HX; Liu LN; Wang Y; Zhang YF; Guo LH; Liu C; Xu JM; Sun LP; Wu J
    Clin Hemorheol Microcirc; 2013; 55(3):375-89. PubMed ID: 23271200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Typical and atypical features of focal nodular hyperplasia of the liver on helical CT images].
    Zheng L; Wu PH; Shen JX; Mo YX; Xie CM; Ruan CM; Li L
    Ai Zheng; 2006 Jul; 25(7):861-5. PubMed ID: 16831278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of superb microvascular imaging in focal liver lesions.
    He MN; Lv K; Jiang YX; Jiang TA
    World J Gastroenterol; 2017 Nov; 23(43):7765-7775. PubMed ID: 29209117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatocellular carcinoma and focal nodular hyperplasia of the liver: differentiation with CT spectral imaging.
    Yu Y; Lin X; Chen K; Chai W; Hu S; Tang R; Zhang J; Cao L; Yan F
    Eur Radiol; 2013 Jun; 23(6):1660-8. PubMed ID: 23306709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review.
    Guo Y; Li W; Cai W; Zhang Y; Fang Y; Hong G
    Int J Med Sci; 2017; 14(7):668-674. PubMed ID: 28824299
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.